Shanghai MicroPort EV MedTech Co. Ltd. A (688351) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Shanghai MicroPort EV MedTech Co. Ltd. A ¥2.45, price ¥17.06, upside -85.6%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Shanghai MicroPort EV MedTech Co. Ltd. A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
49‑month range ¥11.81 – ¥28.58 · fair‑value band ¥2.42 – ¥2.45 · the ¥17.06 price screens above the ¥2.45 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Shanghai MicroPort EV MedTech Co. Ltd. A in your weekly email
Every Wednesday you see whether Shanghai MicroPort EV MedTech Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally.
Show more
Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and system navigational solutions; access conventional solutions; cryoablation solutions; and robotic magnetic navigation solutions. It also exports its products to France, Italy, Bulgaria, Brazil, and Thailand. The company was formerly known as Shanghai Wei Chuang Electrophysiology Medical Technology Co., Ltd. and changed its name to Shanghai MicroPort EP MedTech Co., Ltd. in April 2016. Shanghai MicroPort EP MedTech Co., Ltd. was founded in 2010 and is based in Shanghai, the People's Republic of China.
Stock analysis
Shanghai MicroPort EV MedTech Co. Ltd. A (688351) currently trades at ¥17.06, while our model-based Fair Value estimate is ¥2.45, 85.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥3.45 per share, and 0 of the 16 models we run sit above the ¥17.06 price.
Bear case: the Economic Profit group reads lowest at ¥1.18, and 16 of the 16 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥2.42 (bear) to ¥2.45 (bull), the price of ¥17.06 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 56/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Shanghai MicroPort EV MedTech Co. Ltd. A reported revenue of 465M CNY in FY2025 versus 190M CNY in FY2021, a compound +25.0%/yr. Reported net income was 51.1M CNY in FY2025.
Key figures
Market cap 9.8B CNY (≈ $1.5B) · P/E ratio 131.2 · P/S ratio 14.4 · EPS (TTM) ¥0.1300 · Dividend yield 0.1% · Net margin 11.0% · Return on equity 3.5% · Return on assets (EBIT) 0.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −86%, 688351 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (¥0.0300 to ¥5.15). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ¥2.42Fair Value ¥2.45Bull ¥2.45
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.0824 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.57/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+12.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.9%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +53.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+53.8%
Dividend (yield on the price)0.1%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 8%
⚠ Rate on operating basis: 2025 sits 798% above its own trend.
Compare Shanghai MicroPort EV MedTech Co. Ltd. A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 349 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score56 · Above median
Fair Value upside−85.6% · Bottom 25%
Profitability
Return on equity (TTM)3.5% · Above median
Return on assets0.5% · Below median
Net margin (TTM)12.8% · Above median
Operating margin (TTM)5.0% · Below median
Growth and dividend
Revenue growth21.0% · Top 25%
Dividend yield (TTM)0.1% · Bottom 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (TTM)131.2× · Priciest 25%
P/B5.42× · Priciest 25%
P/S (TTM)20.07× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 9
FUTURE (revenue growth)100· sector 31
PAST (return on equity)14· sector 11
HEALTH (low debt)0· sector 97
DIVIDEND (yield)2· sector 39
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Shanghai MicroPort EV MedTech Co. Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/688351
Frequently asked questions
Is Shanghai MicroPort EV MedTech Co. Ltd. A (688351) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥2.45 versus a price of ¥17.06, about −86% upside (overvalued).
What is the fair value of 688351?
Our model-based fair value for Shanghai MicroPort EV MedTech Co. Ltd. A is ¥2.45 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥17.06.
What is the quality score of 688351?
Shanghai MicroPort EV MedTech Co. Ltd. A has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Our model-based price target is the fair value of ¥2.45 (as of Sep 24, 2026) from 16 valuation models. Cautious scenario ¥2.42, optimistic scenario ¥2.45. It is a calculation from audited fundamentals, not an analyst target.
What is the Shanghai MicroPort EV MedTech Co. Ltd. A stock forecast for 2026?
Our models put fair value at ¥2.45, about −86% upside versus a price of ¥17.06 (overvalued). Cautious scenario ¥2.42, optimistic scenario ¥2.45. The calculation is refreshed regularly with new filings.
What is the revenue of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Shanghai MicroPort EV MedTech Co. Ltd. A reported trailing-twelve-month revenue of about 486M CNY (latest available figure, as of Sep 24, 2026).
Does Shanghai MicroPort EV MedTech Co. Ltd. A pay a dividend?
Shanghai MicroPort EV MedTech Co. Ltd. A currently shows a dividend yield of about 0.12% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shanghai MicroPort EV MedTech Co. Ltd. A it is ¥2.45 per share (as of Sep 24, 2026), against a price of ¥17.06. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Shanghai MicroPort EV MedTech Co. Ltd. A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 688351 trades above its calculated fair value: price ¥17.06, fair value ¥2.45, a gap of about −86% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 688351?
No. The price is what the market pays today (¥17.06); the fair value is what the company's own numbers justify (¥2.45). For Shanghai MicroPort EV MedTech Co. Ltd. A the two are ¥14.61 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shanghai MicroPort EV MedTech Co. Ltd. A worth?
The market values Shanghai MicroPort EV MedTech Co. Ltd. A at about 9.8B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥17.06; our models calculate a fair value of ¥2.45 per share.
What do the bullish and bearish scenarios say about 688351?
Our models span a range for Shanghai MicroPort EV MedTech Co. Ltd. A: cautious scenario ¥2.42, base ¥2.45, optimistic ¥2.45 per share (as of Sep 24, 2026, price ¥17.06). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 688351?
Shanghai MicroPort EV MedTech Co. Ltd. A trades at a price-to-earnings ratio of 131.2 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥2.45 is built from several models across several years. Other multiples: P/B 5.4, P/S 20.1.
How solid is the balance sheet of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Balance-sheet figures for Shanghai MicroPort EV MedTech Co. Ltd. A (as of Sep 24, 2026): return on equity 3.5%. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is 688351 from its 52-week high?
Shanghai MicroPort EV MedTech Co. Ltd. A trades at ¥17.06, about 38% below its 52-week high of ¥27.50 and 3% above the low of ¥16.53 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of ¥2.45 is for.
Which stocks are comparable to Shanghai MicroPort EV MedTech Co. Ltd. A?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shanghai MicroPort EV MedTech Co. Ltd. A stock attractive at the current price?
The data as of Sep 24, 2026: price ¥17.06, calculated fair value ¥2.45 (−86%), Quality Score 56/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 688351 calculated?
We run Shanghai MicroPort EV MedTech Co. Ltd. A through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥2.45, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Shanghai MicroPort EV MedTech Co. Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The closing price on Sep 30, 2026 was ¥17.06. Our model-based fair value is ¥2.45, about −86% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shanghai MicroPort EV MedTech Co. Ltd. A right now?
The price sits above even our optimistic bull case (¥2.45). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder. The models converge in a tight band (¥2.42 to ¥2.45), unusually little disagreement for a valuation.
Key figures of Shanghai MicroPort EV MedTech Co. Ltd. A
How large is the market capitalisation of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The market capitalisation of Shanghai MicroPort EV MedTech Co. Ltd. A is 9.8B CNY (≈ $1.5B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The price-to-sales ratio of Shanghai MicroPort EV MedTech Co. Ltd. A is 14.4 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Earnings per share at Shanghai MicroPort EV MedTech Co. Ltd. A are ¥0.1300 (price ÷ EPS = P/E 131.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The dividend yield of Shanghai MicroPort EV MedTech Co. Ltd. A is 0.1% (payout 16.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The net margin of Shanghai MicroPort EV MedTech Co. Ltd. A is 11.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The return on equity (ROE) of Shanghai MicroPort EV MedTech Co. Ltd. A is 3.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
On an EBIT basis the return on assets of Shanghai MicroPort EV MedTech Co. Ltd. A is 0.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
The operating margin of Shanghai MicroPort EV MedTech Co. Ltd. A is 5.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Revenue at Shanghai MicroPort EV MedTech Co. Ltd. A is growing +21.0% versus a year earlier (3y avg +21.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shanghai MicroPort EV MedTech Co. Ltd. A (688351)?
Earnings per share at Shanghai MicroPort EV MedTech Co. Ltd. A are growing +62.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Shanghai MicroPort EV MedTech Co. Ltd. A (688351) generate?
The free cash flow of Shanghai MicroPort EV MedTech Co. Ltd. A is −31.3M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Shanghai MicroPort EV MedTech Co. Ltd. A in the live analysis
One click puts Shanghai MicroPort EV MedTech Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
